Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOLEGEND, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-19 to 2024-06-18
Current total value of award: $55884.75
Description: TOTAL SEQ BIOLEGEND BRAND ANTIBODIES  (AMBIS #2175486)